Stay updated on Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a software version update.
    Difference
    0.0%
    Check dated 2026-05-18T05:48:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed platform/version revision was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:41:41.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:10:41.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The site update adds Revision: v3.5.0 and removes Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:14:32.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T12:51:59.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The page displays a new revision tag: Revision: v3.4.2, replacing Revision: v3.4.1. This appears to be a metadata/version update rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-02-13T12:55:29.000Z thumbnail image

Stay in the know with updates to Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.